estimate heritability, to infer genetic overlap between traits and to predict phenotypes based 31 on genetic profile or that of other phenotypes [4,5,[8] [9] [10]. 32 33 While GCTA, LDSC and PRS can all be exploited to infer heritability and shared aetiology 34 among complex traits, PRS is the only approach that provides an estimate of genetic 35 propensity to a trait at the individual-level. In the standard approach [4,[11][12][13], polygenic risk 36 scores are calculated by computing the sum of risk alleles corresponding to a phenotype of 37 interest in each individual, weighted by the effect size estimate of the most powerful GWAS 38 on the phenotype. Studies have shown that substantially greater predictive power can usually 39 be achieved by using PRS rather than a small number of genome-wide significant SNPs 40 [11,14,15]. As an individual-level genome-wide genetic proxy of a trait, PRS are suitable for a 41 range of applications. For example, as well as identifying shared aetiology among traits, PRS 42 have been used to test for genome-wide G*E and G*G interactions [15,16], to perform 43
interest in each individual, weighted by the effect size estimate of the most powerful GWAS 38 on the phenotype. Studies have shown that substantially greater predictive power can usually 39 be achieved by using PRS rather than a small number of genome-wide significant SNPs 40 [11, 14, 15 ]. As an individual-level genome-wide genetic proxy of a trait, PRS are suitable for a 41 range of applications. For example, as well as identifying shared aetiology among traits, PRS 42 have been used to test for genome-wide G*E and G*G interactions [15, 16] , to perform 43
Mendelian Randomisation studies to infer causal relationships, and for patient stratification 44 and sub-phenotyping [14, 15, 17, 18] . Thus, while polygenic scores represent individual genetic 45 predictions of phenotypes, prediction is generally not the end objective, rather these 46 predictions are then typically used for interrogating hypotheses via association testing. 47
Duplicate SNPs: Ensure that there are no duplicated SNPs in either the base or target data 151 since this may cause errors in PRS calculation unless the code/software used specifically 152 checks for duplicated SNPs. 153 154 Sex-check: While sex-check procedures are standard in GWAS QC, they are critical in PRS 155 analyses because errors may generate false-positive associations that are due to sex 156 differences in the target phenotype generated by factors other than autosomal genetics. If the 157 aim is to only model autosomal genetics, then all X and Y chromosome SNPs should be 158 removed from the base and target data to eliminate the possibility of confounding by sex. 159
Proper modelling of the sex chromosomes would improve the predictive power of PRS, but a 160 lack of consensus on how best to analyse the sex chromosomes in GWAS has meant that 161 they have, unfortunately, not generally been considered in PRS studies to date. 162
163
Sample overlap: Sample overlap between the base and target data can result in substantial 164 inflation of the association between the PRS and trait tested in the target data [35] and so 165 must be eliminated either, (1) directly: either removing overlapping samples from the target 166 data, or if this removes most/all target individuals, then in the base data followed by 167 recalculation of the base GWAS, or (2) indirectly: if, and only if, the overlapping samples 168 correspond to the entire target sample, and the GWAS that contributed to the base data is 169 available for use, then the overlap can be eliminated using the analytic solution described in 170
[36]. We expect a correction in more complex scenarios of sample overlap, when these 171 solutions are unavailable, to be an objective of future methods development. 172 173 Relatedness: A high degree of relatedness among individuals between the base and target 174 data can also generate inflation of the association between the PRS and target phenotype. 175
Assuming that the results of the study are intended to reflect those of the general population 176 without close relatedness between the base and target samples, then relatives should be 177 excluded. If genetic data from the relevant base data samples can be accessed, then any 178 closely related individuals (eg. 1 st /2 nd degree relatives) across base and target samples should 179 be removed. If this is not an option, then every effort should be made to select base and target 180 data that are very unlikely to contain highly related individuals. 181 182 Heritability check: A critical factor in the accuracy and predictive power of PRS is the power 183 of the base GWAS data [4] , and so to avoid reaching misleading conclusions from the 184 application of PRS we recommend first performing a heritability check of the base GWAS data. 185
We suggest using a software such as LD Score regression [8] varying degrees of shrinkage can be achieved: some force most effect estimates 220 to zero or close to zero, some mostly shrink small effects, while others shrink the 221 largest effects most. The most appropriate shrinkage to apply is dependent on the 222 underlying mixture of null and true effect size distributions, which are likely a 223 complex mixture of distributions that vary by trait. Since the optimal shrinkage 224 parameters are unknown a priori, PRS prediction is typically optimised across a 225 range of (tuning) parameters (for overfitting issues relating to this, see Section 4.4), 226 which in the case of LDpred, for example, includes a parameter for the fraction of 227 causal variant [38] . 228 229 (ii)
Shrinkage of GWAS effect size estimates
In the P-value selection threshold approach, only those SNPs with a GWAS 230 association P-value below a certain threshold (eg. P < 1x10 SNPs that could be selected is too large to feasibly test given that GWAS are based 245 on millions of SNPs. 246
Controlling for Linkage Disequilibrium

247
The association tests in GWAS are typically performed one-SNP-at-a-time, which, combined 248 with the strong correlation structure across the genome, makes identifying the independent 249 genetic effects (or best proxies of these if not genotyped/imputed) extremely challenging. 250
While the power of GWAS can be increased by conditioning on the effects of multiple SNPs 251 simultaneously [39] , this requires access to raw data on all samples, so researchers generally 252 need to exploit standard GWAS (one-SNP-at-a-time) summary statistics to compute polygenic 253 scores. There are two main options for approximating the PRS that would have been 254 generated from full conditional GWAS: (i) SNPs are clumped so that the retained SNPs are 255 largely independent of each other and thus their effects can be summed, assuming additivity, 256
(ii) all SNPs are included and the linkage disequilibrium (LD) between them is accounted for. 257
Usually option (i) is chosen in the 'standard approach' to polygenic scoring, involving P-value 258 thresholding, while option (ii) is generally favoured in methods that implement traditional 259 shrinkage methods [19, 38] (see Table 1 ). In relation to (i), some researchers, however, prefer 260 to perform the P-value thresholding approach without clumping, meaning that the effects of 261 correlated SNPs are summed as though they were independent. While breaking this 262 assumption may lead to minimal losses in some scenarios [ 
PRS units
278
When calculating PRS, the units of the GWAS effect sizes determine the units of the PRS; 279 e.g. if calculating a height PRS using effect sizes from a height GWAS that are reported in 280 centimetres (cm), then the resulting PRS will also be in units of cm. PRS may then be 281 standardised, dividing by the number of SNPs to ensure a similar scale irrespective of number 282 of SNPs included, or standardised to a standard normal distribution. However, the latter 283 discards information that may wish to be retained, since the absolute values of the PRS may 284 be useful in detecting problems with the calculation of the PRS or the sample, identifying 285 outliers, comparing or combining PRS across different samples, or even detecting the effects 286 of natural selection. Negative selection against effect alleles could result in a PRS with a mean 287 negative value due to effect alleles being at lower frequency than non-effect alleles on average, 288 and the opposite for traits under positive selection. 289
290
In calculating PRS on a binary (case/control) phenotype, the effect sizes used as weights are 291 typically reported as log Odds Ratios (log(ORs)). Assuming that relative risks on a disease 292 accumulate on a multiplicative rather than additive scale [40] , then PRS should be computed 293 as a summation of log(OR)-weighted genotypes. It is important for subsequent interpretation 294 to know which logarithmic scale was used since the PRS will take the same units and will be 295 needed to transform back to an OR scale. environmental risk factors for the trait also differ between the two -both highly likely in most 309 PRS studies -then there is a danger that an association between the PRS and target trait can 310 be generated by differences at null SNPs. Confounding is potentially reintroduced even if the 311 GWAS had controlled for population structure perfectly, because this does not account for 312 correlated differences in allele frequencies and risk factors between the base and target data. 313
When the base and target samples are drawn from the same or genetically similar populations, 314 stringent control for structure in the PRS analysis itself (e.g. including a large number of PCs) 315 should suffice to avoid false-positive findings, but we recommend in general that extreme 316 caution is taken given dramatic differences in PRS distributions observed between populations 317 [44] [45] [46] . While these observations do not imply large differences in aetiology across 318 populations -although genuine differences due to variation in the environment, culture and 319 selection pressures are likely to contribute -they do question the reliability of PRS analyses 320 using base and target data from different populations that do not rigorously address the issue 321 of potential confounding from geographic stratification [45] . It is also important to be wary of 322 the fact that highly significant results can be observed due to subtle confounding when 323 exploiting large sample sizes. Note that we use the term 'population' here in a statistical sense: 324 problems of population structure are just as relevant within-country given differences in the 325 genetics and environment between individuals in the base and target samples. We expect the 326 issue of the generalisability of PRS across populations to be an active area of methods 327 development in the coming years [46, 47] . 328 
Predicting Different Traits and exploiting multiple PRS
Interpretation and Presentation of Results
358
If performing individual prediction is the end objective -for example, to make clinical decisions 359 about individual patients -then the most predictive polygenic score method (known at the 360 time) should be applied to the most powerful base sample available on the relevant trait, in 361 order to optimise accuracy of the individual PRS. Little interpretation or presentation of results 362 are required in this setting, and thus Section 4 is devoted to the primary use of PRS in 363 association testing of scientific hypotheses. Once PRS have been calculated, selecting from 364 the options described in Section 3, typically a regression is then performed in the target sample, 365
with the PRS as a predictor of the target phenotype, and covariates included as appropriate. 366
Association and goodness-of-fit metrics
367
A typical PRS study involves testing evidence for an association between a PRS and a trait 368 or measuring the extent of the association in the entire or specific strata of the sample. The 369 standard ways of measuring associations in epidemiology, and their related issues, apply here. 370
The association between PRS and outcome can be measured with the standard association 371 or goodness-of-fit metrics, such as the effect size estimate (beta or OR), phenotypic variance 372 explained (R 2 ), area under the curve (AUC), and P-value corresponding to a null hypothesis 373 of no association. The PRS for many traits are such weak proxies of overall genetic burden 374 (presently) that the phenotypic variance that they explain is often very small (R 2 < 0.01), 375 although this is not important if the aim is only to establish whether an association exists. 376
However, present evidence on the ubiquity of pleiotropy across the genome [51] 
